Sanofi Partners With Apeiron And Evotec To Develop Drug For Blood Cancers And Solid Tumors French drug company Sanofi reports that it is teaming up with biotech companies Evotec of Germany and Apeiron Biologics of Austria to develop new small molecule-based immuno-oncology treatments to treat solid and hematological cancers. by Ted Ranosa
'Spray and Pray' iMessage Scam Haunts iPhone Owners: How to Avoid Losing Your Hard-Earned Money From it
Hong Kong University Brings Albert Einstein to Life Using AI, Transforming Him into a Virtual Lecturer